Eflucimibe
Eflucimibe (L0081) is an ACAT inhibitor used in research to study atherosclerosis and hyperlipidemia. It is applied in both in vitro enzymatic assays and in vivo animal models to investigate lipid metabolism and cardiovascular disease mechanisms.
Product Specifications
CAS Number
202340-45-2
Product Name Alternative
ACAT, L0081, L-0081, L 0081, F12511, F-12511, F 12511, Eflucimibe
Field of Research
Metabolism Research
Purity
98.56% (May vary between batches)
Solubility
10% DMSO+90% Corn Oil:1.5 mg/mL (3.19 mM) ; DMSO:15 mg/mL (31.93 mM)
Smiles
[C@H] (C (NC1=C (C) C (C) =C (O) C (C) =C1) =O) (SCCCCCCCCCCCC) C2=CC=CC=C2
Molecular Formula
C29H43NO2S
Molecular Weight
469.72
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![(E)-5-[2-(Beznyloxy)2-[2,5-bis(benzyloxy)phenyl]ethenyl]-benzoic Acid](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
MBS6092388-01 10 mg
(E)-5-[2-(Beznyloxy)2-[2,5-bis(benzyloxy)phenyl]ethenyl]-benzoic Acid
Sign In for Pricing
View Details MBS6092388-02 5x 10 mg
(E)-5-[2-(Beznyloxy)2-[2,5-bis(benzyloxy)phenyl]ethenyl]-benzoic Acid
Sign In for Pricing
View Details